Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $1.44, but opened at $1.60. Akso Health Group shares last traded at $1.54, with a volume of 1,451 shares.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on AHG shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Akso Health Group in a research note on Friday, July 17th. Wall Street Zen raised Akso Health Group to a “sell” rating in a research note on Saturday, May 2nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Akso Health Group currently has an average rating of “Sell”.
Check Out Our Latest Research Report on AHG
Akso Health Group Stock Performance
Institutional Investors Weigh In On Akso Health Group
A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC purchased a new stake in shares of Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 16,748 shares of the company’s stock, valued at approximately $27,000. Hedge funds and other institutional investors own 1.21% of the company’s stock.
About Akso Health Group
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Recommended Stories
- Five stocks we like better than Akso Health Group
- Is Buying a Launch Company AST SpaceMobile’s Next Vertical Integration Move?
- AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle
- The 2026 Blueprint: 6 Stocks for a Brand New Portfolio
- Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
